Position in EWTX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$14,093,604
+$1,655,979 QoQ
Shares Held
447,416
-10.7% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in EWTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,093,604 | 447,416 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $12,437,625 | 501,214 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $3,587,198 | 221,159 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,936,508 | 223,990 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,967,512 | 225,796 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,780,865 | 253,965 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $7,863,514 | 294,624 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,925,290 | 329,000 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $6,000,960 | 329,000 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,369,520 | 308,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,707,540 | 298,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,309,500 | 298,000 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,987,660 | 298,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,664,120 | 298,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,869,600 | 190,000 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||